The present invention relates to antagonists of GM-CSF for use in the treatment of osteoarthritic pain in a subject, wherein said antagonist is an antibody specific for GM-CSF or an antibody specific for the GM-CSF receptor; and to compositions comprising said antagonists of GM-CSF for said use.